Affordable Access

Contrast-enhanced ultrasound monitoring of perfusion changes in hepatic neuroendocrine metastases after systemic versus selective arterial 177Lu/90Y-DOTATOC and 213Bi-DOTATOC radiopeptide therapy.

Authors
Type
Published Article
Journal
Experimental oncology
Publication Date
Volume
35
Issue
2
Pages
122–126
Identifiers
PMID: 23828389
Source
Medline
License
Unknown

Abstract

CEUS is available and radiation free technique which showed comparable results for perfusion and diameter of liver metastases compared to CE-CT. Intensity reduction in an arterial phase CEUS can be seen as a positive sign indicating long term tumor response to treatment. Therefore CEUS may be considered as an imaging modality for monitoring early treatment after focal alpha and beta targeted therapy.

Statistics

Seen <100 times